Nuzenio

Tradingview Dftx

Tradingview Dftx entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 10 latest news signals 1 publisher sources 100/100 entity strength

Latest news

Definium Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Thu, 06 Aug 2026 21:01:50 GMTDefinium Therapeutics, Inc. Q2 2026: Net loss $(159.0)M, Diluted loss per share $(1.44) — 10-Q Summary - TradingViewTradingView · Thu, 06 Aug 2026 20:36:00 GMTDFTX: $1.1B cash, positive Phase 3 MDD data, and major equity raise drive clinical progress - TradingViewTradingView · Thu, 06 Aug 2026 20:17:50 GMTDefinium Therapeutics reports $1.1B cash, $159.0M Q2 net loss and positive Phase 3 MDD topline - TradingViewTradingView · Thu, 06 Aug 2026 20:13:04 GMTDFTX: Strong Phase 3 efficacy data and robust cash position support continued pipeline advancement - TradingViewTradingView · Thu, 06 Aug 2026 20:07:24 GMTDFTX: Record phase III efficacy for DT120 ODT in MDD; GAD data and robust cash position drive momentum - TradingViewTradingView · Thu, 06 Aug 2026 15:02:46 GMTDFTX Q2'26 Earnings: EPS estimate is (0.54) USD - TradingViewTradingView · Wed, 05 Aug 2026 11:00:47 GMTWeekly Recap: Wells Fargo starts coverage $68 target and Q2 results Aug 6 - TradingViewTradingView · Mon, 03 Aug 2026 11:33:04 GMT

Timeline

Thu, 06 Aug 2026 21:01:50 GMTDefinium Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary - TradingView
Thu, 06 Aug 2026 20:36:00 GMTDefinium Therapeutics, Inc. Q2 2026: Net loss $(159.0)M, Diluted loss per share $(1.44) — 10-Q Summary - TradingView
Thu, 06 Aug 2026 20:17:50 GMTDFTX: $1.1B cash, positive Phase 3 MDD data, and major equity raise drive clinical progress - TradingView
Thu, 06 Aug 2026 20:13:04 GMTDefinium Therapeutics reports $1.1B cash, $159.0M Q2 net loss and positive Phase 3 MDD topline - TradingView
Thu, 06 Aug 2026 20:07:24 GMTDFTX: Strong Phase 3 efficacy data and robust cash position support continued pipeline advancement - TradingView
Thu, 06 Aug 2026 15:02:46 GMTDFTX: Record phase III efficacy for DT120 ODT in MDD; GAD data and robust cash position drive momentum - TradingView

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Tradingview Dftx.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

1 distinct publisher/source names are currently connected to this entity page.